Although a recent study investigated the effects of antibiotics combined with PRP therapy on pregnancy outcomes following FET in RIF patients with CE (14), our research highlighted the efficacy of PRP monotherapy on the expression of endometrial CD138+ plasma cells and the pregnancy outcomes and further unraveled the underlying regulatory mechanisms of PRP in the endometrium of patients with persistent CE. This evidence concerns the gene SDC1 and cholesteryl ester measurement.